Advisory Board

Our advisors bring world-leading expertise in Parkinson's disease, clinical pharmacology and drug formulation.

Fabrizio Stocchi, MD, PhD

Parkinson's disease and movement disorders

Fabrizio Stocchi is Professor of Neurology and Director of the Parkinson's disease and movement disorders research centre at IRCCS San Raffaele Pisana in Rome, and an advisor to the Institute for Parkinson's Disease Research in Vicenza. In the 1980s he helped pioneer the concept of continuous dopaminergic stimulation, and he has designed and led numerous clinical trials in Parkinson's disease. He is a member of 11 professional societies.

Mikael Thomsen, PhD

Clinical pharmacology and drug development

Mikael Thomsen is a co-founder of Contera Pharma and several other international biotech companies. He has worked at Novartis, Novo Nordisk and the US Food and Drug Administration (FDA), and has held senior roles including Chief Scientific Officer and Chief Development Officer. A clinical pharmacologist by training, he holds degrees in pharmacy, human biology, pharmacology and toxicology, and pharmaceutical medicine, and has authored more than 50 publications.

René Holm, PhD

Pharmaceutical formulation

René Holm has been Professor of Pharmaceutical Physical Chemistry at the University of Southern Denmark since 2021 and is an honorary professor at Roskilde University. Before that he worked at H. Lundbeck and Janssen, where he led parenteral and liquid formulation development. He has co-authored more than 240 peer-reviewed articles and patents.